Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine added to ketamine for pediatric endoscopy sedation
IRCT20211108053008N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine and ketamine in No canonical single disease; term refers to multiple upper gastrointestinal tract diseases (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Heart rate, Mean arterial pressure and 3 more. Started Jan 2022; status: completed.
02
Drugs
lidocaineketamine
03
Conditions
No canonical single disease; term refers to multiple upper gastrointestinal tract diseases
Beyond the preview
Go deeper on IRCT20211108053008N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211108053008N1.